[CLSTR]
< Back to situation

[REVISION HISTORY]

Candida auris outbreak in US hospitals

Updated 2 times since CLSTR started tracking revisions of this situation.

What changed

2026-08-10 21:23 UTC → 2026-08-13 14:56 UTC · added removed

The U.S. Centers for Disease Control and Prevention (CDC) continues to monitor Candida auris, a drug-resistant fungus, as it spreads through healthcare settings. As of mid-July 2026, the agency reported over 3,000 clinical cases. While one tally noted 3,130 cases in 23 states, a preliminary release cited 3,437 cases across 27 states, including 873 cases in California. Texas maintains the highest infection count with 706 cases, followed by Michigan (503) and Illinois (366). Cases are primarily concentrated in hospitals, long-term acute-care facilities, and skilled-nursing homes, specifically affecting patients with invasive devices like catheters or ventilators. Laboratory data indicate high resistance levels: over 95% of isolates resist fluconazole, approximately 15% resist amphotericin B, and roughly 1% resist echinocandins, with fewer than 1% being pan-resistant. Although case numbers rise annually, the CDC notes the growth rate has slowed since 2022. Recent research published in has provided insight into how the journal fungus persists and evades the immune system. A study in Science by scientists at the University of California, San Francisco has provided insight into how the fungus persists on human skin. The study suggests C. auris exploits the body’s immune response by settling settles into hair follicles. By exposing chitin, follicles, stimulating interferon gamma to prevent the pathogen triggers an immune signal that allows it skin from clearing the infection. Furthering efforts to hunker down combat the pathogen, researchers from institutions including the Max Planck Institute and the University of Exeter published a study in follicles rather than being eliminated. This colonization mechanism facilitates transmission within healthcare environments, even when Angewandte Chemie. They identified a specific sugar structure on the individual remains asymptomatic. The CDC maintains its classification fungus’s surface, which has led to the development of Candida auris a synthetic molecule that could serve as an urgent, critical public-health threat. a basis for vaccines, protective antibodies, and rapid diagnostic tests similar to lateral flow devices.

Versions

  1. 2026-08-13 14:56 UTC Candida auris outbreak in US hospitals
  2. 2026-08-10 21:23 UTC Candida auris outbreak in US hospitals
  3. 2026-08-07 14:23 UTC Candida auris outbreak in US hospitals

Only revisions since CLSTR began indexing content versions appear here. Select a version to see what changed compared to the one before it.